If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Yusuke Tanigawara is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Pharmacokinetics Medicine & Life Sciences
P-Glycoprotein Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Population Medicine & Life Sciences
Digoxin Medicine & Life Sciences
Kidney Medicine & Life Sciences
Genotype Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1981 2019

  • 8533 Citations
  • 41 h-Index
  • 181 Article

Cerebrospinal pharmacokinetic and pharmacodynamic analysis of efficacy of meropenem in paediatric patients with bacterial meningitis

Ohata, Y., Tomita, Y., Sunakawa, K., Drusano, G. L. & Tanigawara, Y., 2019 Sep 1, In : International journal of antimicrobial agents. 54, 3, p. 292-300 9 p.

Research output: Contribution to journalArticle

Bacterial Meningitides
Cerebrospinal Fluid

Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer

Kawata, T., Higashimori, M., Itoh, Y., Tomkinson, H., Johnson, M. G., Tang, W., Nyberg, F., Jiang, H. & Tanigawara, Y., 2019 Jan 1, In : Cancer Chemotherapy and Pharmacology.

Research output: Contribution to journalArticle

Pulmonary diseases
Interstitial Lung Diseases
Non-Small Cell Lung Carcinoma

Application of PBPK Modeling and Virtual Clinical Study Approaches to Predict the Outcomes of CYP2D6 Genotype-Guided Dosing of Tamoxifen

Nakamura, T., Toshimoto, K., Lee, W., Imamura, C., Tanigawara, Y. & Sugiyama, Y., 2018 Jul 1, In : CPT: Pharmacometrics and Systems Pharmacology. 7, 7, p. 474-482 9 p.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP2D6
1 Citation (Scopus)

Individualized Dosing of Axitinib Based on First-Dose Area Under the Concentration–Time Curve for Metastatic Renal-Cell Carcinoma

Miura, Y., Imamura, C., Uchino, K., Kishida, T., Matsubara, N., Shinojima, T., Kondo, K., Hongo, F., Yoshimura, K., Tanigawara, Y. & Takano, T., 2018 Jan 1, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Area Under Curve
Disease-Free Survival
Survival Rate
Confidence Intervals
6 Citations (Scopus)

Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker

Mori, Y., Kasai, H., Ose, A., Serada, M., Ishiguro, M., Shiraki, M. & Tanigawara, Y., 2018 Feb 8, (Accepted/In press) In : Osteoporosis International. p. 1-9 9 p.

Research output: Contribution to journalArticle

zoledronic acid
Bone Resorption
Bone Density
Theoretical Models